title: Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject.
authors.forename: Stefano
authors.initials: S
authors.lastname: Bonora
authors.forename: Andrea
authors.initials: A
authors.lastname: Calcagno
authors.forename: Silvia
authors.initials: S
authors.lastname: Fontana
authors.forename: Antonio
authors.initials: A
authors.lastname: D'Avolio
authors.forename: Marco
authors.initials: M
authors.lastname: Siccardi
authors.forename: Federico
authors.initials: F
authors.lastname: Gobbi
authors.forename: Giovanni
authors.initials: G
authors.lastname: Di Perri
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000493:pharmacokinetics / Q000627:therapeutic use; D000075202:Contraindications; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000493:pharmacokinetics / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011753:Pyrones / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D013449:Sulfonamides
chemical_list: D019380:Anti-HIV Agents; D000927:Anticonvulsants; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; D019438:Ritonavir; D010634:Phenobarbital; C107201:tipranavir